Venetoclax-Targeted Therapy in t(11;14) AL Amyloidosis Patients after Frontline Daratumumab and Cybord: A Retrospective Analysis from the French Amyloidosis NetworkMurielle Roussel, Arnaud Jaccard, Ornella Rizzo et al.|Blood|2022Cited by 3